Theralase Technologies Inc. (TSXV: TLT)
Canada
· Delayed Price · Currency is CAD
0.250
-0.020 (-7.41%)
Dec 20, 2024, 3:59 PM EST
Theralase Technologies Revenue
Theralase Technologies had revenue of 346.58K CAD in the quarter ending September 30, 2024, with 23.51% growth. This brings the company's revenue in the last twelve months to 986.60K, down -4.42% year-over-year. In the year 2023, Theralase Technologies had annual revenue of 1.07M, down -6.00%.
Revenue (ttm)
986.60K
Revenue Growth
-4.42%
P/S Ratio
58.93
Revenue / Employee
49.33K
Employees
20
Market Cap
61.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | 964.05K | -770.02K | -44.41% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.33B |
Bausch Health Companies Inc. | 12.80B |
WELL Health Technologies Corp. | 957.69M |
dentalcorp Holdings Ltd. | 1.51B |
Curaleaf Holdings, Inc. | 1.83B |
Tilray Brands, Inc. | 1.10B |
Sienna Senior Living Inc. | 867.55M |
Cronos Group Inc. | 150.26M |
Theralase Technologies News
- 12 days ago - Theralase(R) Launches Three New Clinical Study Sites in USA - Accesswire
- 17 days ago - Theralase(R) Launches New Clinical Study Site in Canada - Accesswire
- 17 days ago - Theralase Technologies Inc (TLTFF) Q3 2024 Earnings Call Highlights: Strong Clinical Data and ... - GuruFocus
- 17 days ago - Theralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Theralase(R) Release's 3Q2024 Financial Statements - Accesswire
- 5 weeks ago - Theralase(R) Closes Non-Brokered Private Placement - Accesswire
- 5 weeks ago - Theralase(R) Extends Warrants - Accesswire
- 2 months ago - Theralase(R) Provides Update on Bladder Cancer Clinical Study - Accesswire